Authors' reply obessive-compulsive disorders due to neuroacanthocytosis treated with citalopram [6]

Pharmacopsychiatry

Volumn 40, Issue 2, 2007, Pages 87-

  Habermeyer, B ^a   Fuhr, P ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; SEROTONIN UPTAKE INHIBITOR;

ACANTHOCYTOSIS; CHOREA MINOR; CLINICAL FEATURE; HUMAN; HYPERTRANSLUCENT LUNG; IMAGING SYSTEM; LABORATORY TEST; LETTER; OBSESSIVE COMPULSIVE DISORDER; PRIORITY JOURNAL; CHOREA; HOSPITALIZATION; NOTE; TREATMENT OUTCOME;

CHOREATIC DISORDERS; CITALOPRAM; HUMANS; OBSESSIVE-COMPULSIVE DISORDER; SEROTONIN UPTAKE INHIBITORS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 34247859052     PISSN: 01763679     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-970141     Document Type: Letter

References (4)

1. Allen FH, Krabbe SM, Corcoran PA: A new phenotype (McLeod) in the Kell blood-group system. Vox Sang 1961; 6: 555-560
2. Habermeyer B, Fuhr P, Hiss B et al: Obessive-compulsive disorders due to neuroacanthocytosis treated with citalopram. Pharmacopsychiatry 2006; 39: 193-194
3. Russo D, Redman C, Lee S: Association of XK and Kell blood group proteins. J Biol Chem 1998; 273: 13950-13956
4. Walker RH, Danek A, Dobson-Stone C et al: Developments in neuroacanthocytosis: Expanding the spectrum of choreatic syndromes. Mov Disord 2006, Sep 6; [Epub ahead of print]